Dimethylformamide → 4-{(S)-4-tert-butoxycarbonyl-2-[(6-methyl-2-phenyl-pyrimidine-4-carbonyl)-amino]-butyryl}-piperazine-1-carboxylic acid ethyl ester
Reaction equation
[CH:1]1[CH:6]=[C:5]2N=NN(O)[C:4]2=[CH:3][CH:2]=1.O.[CH3:12][CH2:13][N:14]=[C:15]=[N:16][CH2:17][CH2:18]CN(C)C.Cl.[CH2:24]([O:26][C:27]([N:29]1[CH2:34][CH2:33][N:32]([C:35](=[O:47])[C@@H:36]([NH2:46])[CH2:37][CH2:38][C:39]([O:41][C:42]([CH3:45])([CH3:44])[CH3:43])=[O:40])[CH2:31][CH2:30]1)=[O:28])[CH3:25].[NH4+].[Cl-].CN([CH:53]=[O:54])C>>[CH2:24]([O:26][C:27]([N:29]1[CH2:30][CH2:31][N:32]([C:35](=[O:47])[C@@H:36]([NH:46][C:53]([C:17]2[CH:18]=[C:13]([CH3:12])[N:14]=[C:15]([C:5]3[CH:4]=[CH:3][CH:2]=[CH:1][CH:6]=3)[N:16]=2)=[O:54])[CH2:37][CH2:38][C:39]([O:41][C:42]([CH3:43])([CH3:45])[CH3:44])=[O:40])[CH2:33][CH2:34]1)=[O:28])[CH3:25]Participants
6
Reactant 5
Product 1
Procedure
Intermediate 86.2 (214 mg), HOBT hydrate (168 mg) and EDCI hydrochloride (210 mg) were dissolved in DMF (7 ml). After 15 min stirring, 4-((S)-2-amino-4-tert-butoxycarbonyl-butyryl)-piperazine-1-carboxylic acid ethyl ester (377 mg) was added and the stirring was continued overnight at RT. A saturated NH4Cl solution was added and the mixture was extracted with EA. The org. phases were dried (Na2SO4) and evaporated off. Column chromatography (EA/Hept 1/3 to 1/1) of the crude offered the compound still contaminated by some starting material. It was then taken up in EA and washed with a Na2CO3 solution, dried and evaporated off to give 462 mg of the pure desired compound.
Workup
- waitthe stirring was continued overnight at RT
- extractionthe mixture was extracted with EA
- dry with materialphases were dried (Na2SO4)
- customevaporated off
- washwashed with a Na2CO3 solution
- customdried
- customevaporated off
Sources & evidence
- ORD record
- ord-0610ada155494cdbb256f1f17b3f32d4
- Source dataset
- uspto-grants-2011_11
- Patent number
- US08048881B2
Reaction notes
Loading…